101. A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis.
- Author
-
Wong SJ, Furuya A, Zou J, Xie X, Dupuis AP 2nd, Kramer LD, and Shi PY
- Subjects
- Animals, Antibodies, Viral blood, Antibodies, Viral immunology, Chlorocebus aethiops, Cross Reactions immunology, Dengue immunology, Dengue virology, Dengue Virus immunology, Dengue Virus physiology, Enzyme-Linked Immunosorbent Assay methods, Host-Pathogen Interactions immunology, Humans, Reproducibility of Results, Sensitivity and Specificity, Vero Cells, Viral Envelope Proteins immunology, Viral Nonstructural Proteins immunology, Zika Virus physiology, Zika Virus Infection immunology, Zika Virus Infection virology, Immunoassay methods, Microspheres, Zika Virus immunology, Zika Virus Infection diagnosis
- Abstract
Rapid and accurate diagnosis of infectious agents is essential for patient care, disease control, and countermeasure development. The present serologic diagnosis of Zika virus (ZIKV) infection relies mainly on IgM-capture ELISA which is confounded with the flaw of cross-reactivity among different flaviviruses. In this communication, we report a multiplex microsphere immunoassay (MIA) that captures the diagnostic power of viral envelope protein (that elicits robust, yet cross-reactive antibodies to other flaviviruses) and the differential power of viral nonstructural proteins NS1 and NS5 (that induce more virus-type specific antibodies). Using 153 patient specimens with known ZIKV and/or dengue virus (DENV; a closely related flavivirus) infections, we showed that (i) ZIKV envelope-based MIA is equivalent or more sensitive than IgM-capture ELISA in diagnosing ZIKV infection, (ii) antibody responses to NS1 and NS5 proteins are more ZIKV-specific than antibody response to envelope protein, (iii) inclusion of NS1 and NS5 in the MIA improves the diagnostic accuracy when compared with the MIA that uses envelope protein alone. The multiplex MIA achieves a rapid diagnosis (turnaround time<4h) and requires small specimen volume (10μl) in a single reaction. This serologic assay could be developed for use in clinical diagnosis of ZIKV infection and for monitoring immune responses in vaccine trials., (Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF